회사소개
History
Start of
full-fledged
business
2020-2022
2022
  • 08.Acquired CFS for 1copy™ COVID-19 RT-PCR Dry Kit
  • 06.Selected as preliminary unicorns by The Ministry of SMEs and Startups
  • 04.Acquired CE-IVD for 1drop™ Gluco personal
  • 03. Acquired CFS for 1copy™ COVID-19 Variants Kit
2021
  • 12. Exported 6.5M tests to 35 countries
  • 10. Acquired CE-IVD for 1copy™ COVID-19 MDx Kit Professional
  • 08. Acquired certification for 1drop™ Lipid TC personal (1st in Korea)
  • 06. Acquired CFS for 1copy™ COVID-19 MDx Kit Professional
  • 03. Expanded Workplace (3F Banpo Technopia, 186 Galmachi-ro, Seongnam-si, Gyeonggi-do)
  • 02. Acquired certification for 1drop™ UA personal (1st in Korea)
2020
  • 12. Exported 0.8M tests to 34 countries
  • 05. Acquired FDA-EUA 1copy™ COVID-19 (6th in Korea)
  • 04. Supplied 1copy™ COVID-19 qPCR Kits to Hungarian government (500,000 tests)
  • 03. Acquired Health Canada 1copy™ COVID-19 (1st in Korea)
  • 03. Acquired CFS, CE-IVD for 1copy™ COVID-19 PCR Kit
  • 02. Developed 1copy™ COVID-19 PCR Kit
  • 01. Signed BGI supply deal (23.4M USD/5 years)
Building
foundation
2017-2019
2019
  • 11. Acquired CFS, CE-IVD for 1copy™ BCR-ABL qPCR Kit
  • 11. Acquired CFS, CE-IVD for 1drop™ Hemo/Glu/UA/TC
  • 07. Acquired Quality Management System (ISO13485:2016, KGMP)
2018
  • 12. Established factory
  • 08. Head office relocation
  • 02. Certification of Corporate R&D Center
2017
  • 10. Certification of start-up company
  • 09. Established corporation